诊断为精神障碍的患者在心理治疗前接受戒烟治疗:一项随机对照试验的研究方案
该单中心随机对照试验在门诊心理治疗诊所开展,比较强化戒烟干预与等待对照组对吸烟的精神障碍患者尼古丁依赖、吸烟行为及精神健康症状的影响。干预为指南基础认知行为项目联合数字健康应用,结局在干预前、治疗后及6周和6个月随访评估。
要点
- 精神障碍患者吸烟率为一般人群两倍且烟草消耗量更高,烟草相关健康风险增加。
- 德国临床实践在心理治疗开始前未将烟草依赖视为风险因素,尽管干预需求明确。
- 试验探讨心理治疗前启动强化戒烟项目对烟草依赖程度、吸烟行为和精神健康结局的影响。
核心结论
- 在心理治疗前处理吸烟行为可能显著改善精神健康结局,本试验研究将戒烟策略整合到精神障碍吸烟者心理治疗之前的方案。
- 通过将烟草依赖治疗与其他物质使用障碍的方法对齐,旨在建立并讨论一种全面且符合指南的方法,以改善患者结局并形成 cohesive、整合的治疗吸烟共病精神障碍患者的方法。
研究设计与样本
- 单中心随机对照试验,在门诊心理治疗诊所开展,比较强化戒烟干预与等待对照组。
- 主要结局包括吸烟者尼古丁依赖、吸烟行为及与主要精神障碍相关的精神健康症状,采用方差分析方法分析。
- 戒烟干预由指南基础的认知行为项目联合数字健康应用组成。
- 次要结局包括自我报告自我效能和隐性认知偏倚的变化,以及动机测量、自我效能、隐性趋近倾向和对在线干预的态度作为次要测量,并在探索性分析中作为潜在预测因素、调节因素或中介因素检验。
- 对在线干预的态度仅在基线测量一次,其他所有测量在干预前、治疗后及6周和6个月随访时评估。
临床怎么用
- 作者认为在心理治疗前处理吸烟行为可能显著改善精神健康结局,并研究将戒烟策略整合到精神障碍吸烟者心理治疗之前的方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tobacco use is a leading risk factor for premature mortality. Individuals with mental disorders exhibit a smoking prevalence twice that of the general population and engage in higher levels of tobacco consumption, thereby elevating their risk for tobacco-related health complications. Unlike with other substance use disorders, clinical practice in Germany neglects tobacco dependence as a risk factor prior to the initiation of psychotherapy, despite a clear need for intervention: Prolonged cigarette smoking exacerbates mental health symptoms and influences processes central to psychotherapy, such as implicit cognitive processes and emotion regulation. Moreover, short-term nicotine withdrawal associated with tobacco dependence can undermine motivation, reduce positive reinforcement, and cause emotional instability, potentially hindering efforts to improve mental health or the effectiveness of psychotherapeutic interventions. These factors underscore the importance of integrating smoking cessation strategies prior to formal psychotherapy to optimize the therapeutic process and patient outcomes. This study investigates the effects of initiating an intensified smoking cessation program prior to starting psychotherapy. Main measure outcomes of interest are the degree of tobacco dependence, smoking behavior, and mental health outcomes in smokers with mental disorders. By addressing smoking behavior prior to therapy, this trial seeks to establish a more solid foundation for therapeutic work, potentially improving mental health outcomes and promoting a comprehensive approach to mental health care. METHODS: A single-center randomized controlled trial in an outpatient psychotherapeutic clinic will examine the effects of an intensified smoking cessation intervention versus a waiting control condition. The primary outcome measures include smokers' nicotine dependence, smoking behavior, and mental health symptoms related to their primary mental disorder, analyzed using variance analysis methods. The smoking intervention consists of a common guideline-based cognitive-behavioral program supplemented by a digital health application. Secondary outcomes include changes in self-reported self-efficacy and implicit cognitive biases. In addition, motivational measures, self-efficacy, implicit approach tendencies, and attitudes toward online interventions will be assessed as secondary measures and examined as potential predictors, moderators, or mediators in exploratory analyses. Attitudes toward online interventions will be measured once at baseline, while all other measures will be assessed before the intervention, post-treatment, and at 6-week and 6-month follow-up sessions. DISCUSSION: Addressing smoking behavior before psychotherapy holds potential to significantly enhance mental health outcomes. This study investigates the integration of smoking cessation strategies prior to psychotherapeutic care for cigarette-smoking individuals with mental disorders. By aligning tobacco dependence treatment with approaches used for other substance use disorders, we aim to establish and discuss a comprehensive and guideline-conformant method. This strategy seeks to improve patient outcomes and a cohesive, integrated method for treating smokers with comorbid mental health disorders. TRIAL REGISTRATION: Prospectively registered on ISCRTN on 01.05.2024, reference number ISRCTN12859609.
引用
- Sünkel ET, Neubert M, Machulska A, et al. Smoking cessation treatment prior to psychotherapy for patients with diagnosed mental disorders: study protocol for a randomized controlled trial. Trials. 2025. PMID: 40598571. doi:10.1186/s13063-025-08917-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。